Xylem Inc.XYLNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P21
Within normal range
vs 3Y Ago
-1.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-1.74%
2024-0.86%
202312.62%
20220.98%
20219.09%
2020-2.09%
20191.06%
20185.00%
201763.64%
201615.79%